Pharma: Novartis shares dropped 9% following setbacks in three drug trials, impacting investor confidence and market performance.

Sep 8, 2026 - 05:55
 0  0
Pharma: Novartis shares dropped 9% following setbacks in three drug trials, impacting investor confidence and market performance.
Novartis shares plummeted on Tuesday following disappointing results from its del-desiran drug trial, leaving investors concerned. Stay tuned for updates on how this will impact the company's future! 📉 #Novartis #PharmaNews

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0